RESEARCH-USE BIOSIMILAR ANTIBODY
Ravagalimab
Monoclonal antibody · IgG1
Ravagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used for research of Crohn's disease.
TARGETTNFRSF5
YMonoclonal antibody
CATALOGSC-BS-236
CATALOG NUMBERSC-BS-236
MOLECULAR WEIGHTApprox. 146.04 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ravagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used for research of Crohn's disease.
Ravagalimab is a recombinant research-use antibody directed against TNFRSF5.